Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C.E.R.A. in pre-dialysis chronic renal anemia
NCT00576628Phase 3Completed
- Sponsor
- Roche
- Start
- May 2008
- Primary completion
- Mar 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Primary endpoint: Mean Change in Hb Concentration g/dL Between Baseline and the Efficacy Evaluation Period at Week 36. Started May 2008; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00576628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576628.